Technology

Roland Mattern, director of marketing for eSight, illustrates the use of the company's eSight 4 device to assist patients with central vision loss.

Denise A. Valenti, OD, FAAO, gives key takeaways from her AAOpt 2022 discussion on the impact of marijuana use and driving.

Pinakin Davey, PhD, OD, FAAO, gives key highlights from his AAOpt 2022 presentation, "Management of digital eye strain: comprehensive strategy and nutritional approach."

When combined, intense pulsed light and low-level light therapy—both of which have roots in dermatology—create a synergistic effect that treat dry eye more effectively than one therapy alone.

Adam Ramsey, OD, shares key takeaways from his EyeCon 2022 presentation, "Advances in industry innovations to improve your practice."

The glaucoma field is on the move with significant innovations in a number of treatment areas. Experts discussed the various technologies at the Optometry Times 2022 EyeCon meeting in Marco Island, Florida.

As technology advances and choices grow, you need to personalize patients’ options.

Research indicates that too much technology usage results in negative effects on eyesight.

Brad Sutton, OD, FAAO, FORS, shares highlights from his discussion titled, "Retinal imaging grand rounds," which he co-presented during the 2022 American Academy of Optometry meeting.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

DigitalOptometrics President discusses the pioneering abilities of telemedicine and how the company is paving a new way for doctors to see patients of varying needs.

The web-based, self-guided software application is accessed through touchscreen mobile devices.

When considering the best modality these lenses' stability are superior.

As technology improves, less-invasive treatments save patients time and money.

Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.

Valerie M. Kattouf, OD, discusses going back to the basics of neuro-ophthalmology + managing vision and visual-motor abnormalities in patients.

With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.

Low prediction errors from 2 evaluated formulas shows promise for accurate prediction of IOL formulas in high myopic patients.

Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.

Establish a program in your practice during this Wild West phase of tech.

Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part four.

Advancements enable better diagnosis, treatment of patients.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.

The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.

Mojo Vision's CEO Drew Perkins announced last week that he became the first, and currently only, person to wear the latest prototype of Mojo Lens, an augmented reality-based contact lens.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.

Knowing your glaucoma vitals is key to providing best treatment for patients.

Embracing this new model of care can allow optometric practices to flourish—and may enable earlier detection of conversion from intermediate dry to wet AMD.